EP2861579
Bensamíðafleiður til að hindra virkni ABL1, ABL2 og BCR-ABL1
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
9.5.2013EP published:
21.2.2018EP application number:
13730652.8
EP translation filed:
18.4.2018Grant published:
15.5.2018EPO information:
European Patent Register
Max expiry date:
8.5.2033Expiry date:
8.5.2026Next due date:
31.5.2026
Title:
BENZAMIDE DERIVATIVES FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1
Timeline
Today
9.5.2013EP application
21.2.2018EP Publication
18.4.2018Translation submitted
15.5.2018Registration published
8.5.2026Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
DODD, Stephanie KayAddress:
Cambridge, Massachusetts, US
Name:
FURET, PascalAddress:
Basel, CH
Name:
GROTZFELD, Robert MartinAddress:
Basel, CH
Name:
JONES, Darryl BrynleyAddress:
Basel, CH
Name:
MANLEY, PaulAddress:
Basel, CH
Name:
MARZINZIK, AndreasAddress:
Basel, CH
Name:
PELLE, Xavier Francois AndreAddress:
Basel, CH
Name:
SALEM, BahaaAddress:
Basel, CH
Name:
SCHOEPFER, JosephAddress:
Basel, CH
Name:
JAHNKE, WolfgangAddress:
Basel, CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201261647174 PDate:
15.5.2012Country:
US
Number:
201361790967 PDate:
15.3.2013Country:
US
Supplementary protection
SPC number:
SPC408
Classification
Categories:
C07D 401/14, C07D 401/04, C07D 403/10, C07D 213/82, A61K 31/4439, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 24.4.2018
Expires: 8.5.2019
Payer: Árnason Faktor
Number: 7
Paid: 24.4.2019
Expires: 8.5.2020
Payer: Árnason Faktor
Number: 8
Paid: 27.4.2020
Expires: 8.5.2021
Payer: Árnason Faktor ehf.
Number: 9
Paid: 26.4.2021
Expires: 8.5.2022
Payer: Árnason Faktor ehf.
Number: 10
Paid: 28.4.2022
Expires: 8.5.2023
Payer: Árnason Faktor ehf.
Number: 11
Paid: 28.4.2023
Expires: 8.5.2024
Payer: Árnason Faktor ehf.
Number: 12
Paid: 23.4.2024
Expires: 8.5.2025
Payer: Árnason Faktor ehf.
Number: 13
Paid: 9.5.2025
Expires: 8.5.2026
Payer: Árnason Faktor ehf.